ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Orthofix Medical Inc

Orthofix Medical Inc (OFIX)

18.13
0.20
(1.12%)
마감 21 1월 6:00AM
18.13
-0.03
(-0.17%)
시간외 거래: 7:30AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
18.13
매수가
13.27
매도가
22.00
거래량
100,364
17.81 일간 변동폭 18.4546
12.08 52주 범위 20.7299
market_cap
전일 종가
17.93
개장가
18.11
최근 거래 시간
275
@
18.13
(priorref)
마지막 거래 시간
재정 규모
US$ 1,813,801
VWAP
18.0722
평균 볼륨(3m)
269,019
발행 주식
38,214,187
배당수익률
-
주가수익률
-4.58
주당순이익(EPS)
-3.96
매출
746.64M
순이익
-151.4M

Orthofix Medical Inc 정보

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing prod... Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients. 더 보기

섹터
Surgical,med Instr,apparatus
산업
Medical Instruments & Machines
웹사이트
본부
Lewisville, Texas, USA
설립됨
1980
Orthofix Medical Inc is listed in the Surgical,med Instr,apparatus sector of the 나스닥 with ticker OFIX. The last closing price for Orthofix Medical was US$17.93. Over the last year, Orthofix Medical shares have traded in a share price range of US$ 12.08 to US$ 20.7299.

Orthofix Medical currently has 38,214,187 shares in issue. The market capitalisation of Orthofix Medical is US$685.18 million. Orthofix Medical has a price to earnings ratio (PE ratio) of -4.58.

OFIX 최신 뉴스

Orthofix to Participate in Upcoming Investor Conferences

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
11.589.5468277945616.5518.1616.4334740517.33872966CS
41.217.1513002364116.9218.1616.4322243217.36143493CS
122.2314.025157232715.920.729915.726901918.18921294CS
261.8711.500615006216.2620.729914.140125818817.14549942CS
524.7835.805243445713.3520.729912.0829702115.29938949CS
156-15.4-45.929018789133.5336.1259.57532411116.24343641CS
260-29.62-62.031413612647.7548.59.57523595519.86472209CS

OFIX - Frequently Asked Questions (FAQ)

What is the current Orthofix Medical share price?
The current share price of Orthofix Medical is US$ 18.13
How many Orthofix Medical shares are in issue?
Orthofix Medical has 38,214,187 shares in issue
What is the market cap of Orthofix Medical?
The market capitalisation of Orthofix Medical is USD 685.18M
What is the 1 year trading range for Orthofix Medical share price?
Orthofix Medical has traded in the range of US$ 12.08 to US$ 20.7299 during the past year
What is the PE ratio of Orthofix Medical?
The price to earnings ratio of Orthofix Medical is -4.58
What is the cash to sales ratio of Orthofix Medical?
The cash to sales ratio of Orthofix Medical is 0.93
What is the reporting currency for Orthofix Medical?
Orthofix Medical reports financial results in USD
What is the latest annual turnover for Orthofix Medical?
The latest annual turnover of Orthofix Medical is USD 746.64M
What is the latest annual profit for Orthofix Medical?
The latest annual profit of Orthofix Medical is USD -151.4M
What is the registered address of Orthofix Medical?
The registered address for Orthofix Medical is 3451 PLANO PARKWAY, LEWISVILLE, TEXAS, 75056
What is the Orthofix Medical website address?
The website address for Orthofix Medical is www.orthofix.com/
Which industry sector does Orthofix Medical operate in?
Orthofix Medical operates in the MEDICAL INSTRUMENTS & MACHINES sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

OFIX Discussion

게시물 보기
Monksdream Monksdream 11 월 전
OFIX 10Q due March 5
👍️0
Renee Renee 7 년 전
OFIX, Jeffrey Hammel, CPA, Brian McCollum, Kenneth Mack and Bryan McMillan SEC Litigation:

https://www.sec.gov/litigation/admin/2018/34-82933.pdf

👍️0
Renee Renee 13 년 전
OFIX: SEC Litigation:

http://www.sec.gov/litigation/litreleases/2012/lr22412.htm

U.S. SECURITIES AND EXCHANGE COMMISSION

Litigation Release No. 22412 /July 11, 2012

Securities and Exchange Commission v. Orthofix International N.V., United States District Court for the Eastern District of Texas, Case No. 4:12-CV-419 (filed July 10, 2012)

SEC CHARGES ORTHOFIX INTERNATIONAL WITH FCPA VIOLATIONS


The Securities and Exchange Commission today charged Texas-based medical device company Orthofix International N.V. with violating the Foreign Corrupt Practices Act (FCPA) when a subsidiary paid routine bribes referred to as “chocolates” to Mexican officials in order to obtain lucrative sales contracts with government hospitals.

The SEC alleges that Orthofix’s Mexican subsidiary Promeca S.A. de C.V. bribed officials at Mexico’s government-owned health care and social services institution Instituto Mexicano del Seguro Social (IMSS). The “chocolates” came in the form of cash, laptop computers, televisions, and appliances that were provided directly to Mexican government officials or indirectly through front companies that the officials owned. The bribery scheme lasted for several years and yielded nearly $5 million in illegal profits for the Orthofix subsidiary.

Orthofix agreed to pay $5.2 million to settle the SEC’s charges.

According to the SEC’s complaint filed in U.S. District Court for the Eastern District of Texas, the bribes began in 2003 and continued until 2010. Initially, Promeca falsely recorded the bribes as cash advances and falsified its invoices to support the expenditures. Later, when the bribes got much larger, Promeca falsely recorded them as promotional and training costs. Because of the bribery scheme, Promeca’s training and promotional expenses were significantly over budget. Orthofix did launch an inquiry into these expenses, but did very little to investigate or diminish the excessive spending. Later, upon discovery of the bribe payments through a Promeca executive, Orthofix immediately self-reported the matter to the SEC and implemented significant remedial measures. The company terminated the Promeca executives who orchestrated the bribery scheme.

The SEC’s proposed settlement is subject to court approval. Orthofix consented to a final judgment ordering it to pay $4,983,644 in disgorgement and more than $242,000 in prejudgment interest. The final judgment would permanently enjoined the company from violating Sections 13(b)(2)(A) and 13(b)(2)(B) of the Securities Exchange Act of 1934. Orthofix also agreed to certain undertakings, including monitoring its FCPA compliance program and reporting back to the SEC for a two-year period.

Orthofix also disclosed today in an 8-K filing that it has reached an agreement with the U.S. Department of Justice to pay a $2.22 million penalty in a related action.

The SEC’s investigation was conducted by Carol Shau and Alka N. Patel in the Los Angeles Regional Office. The SEC acknowledges and appreciates the assistance of the U.S. Department of Justice’s Criminal Division-Fraud Section and the Federal Bureau of Investigation.

SEC Complaint:

http://www.sec.gov/litigation/complaints/2012/comp22412.pdf
👍️0
Penny Roger$ Penny Roger$ 13 년 전
~ Monday! $OFIX ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $OFIX ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=OFIX&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=OFIX&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=OFIX
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=OFIX#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=OFIX+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=OFIX
Finviz: http://finviz.com/quote.ashx?t=OFIX
~ BusyStock: http://busystock.com/i.php?s=OFIX&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=OFIX >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.
👍️0
Penny Roger$ Penny Roger$ 13 년 전
Orthofix International N.V. (Orthofix) is a diversified orthopedic products company. The Company offers a range of surgical and non-surgical products for the Spine, Orthopedics, Sports Medicine and Other Products market sectors. The Company’s products are designed to address the bone-and-joint health needs of patients of all ages. It designs, develops, manufactures, markets and distributes medical equipment used principally by musculoskeletal medical specialists for orthopedic applications. The Company operates in three segments: Spine, Orthopedics and Sports Medicine. Its primary research and development facilities are located in Fairfield, New Jersey; Verona, Italy; Lewisville, Texas; and Vista, California. During the year ended December 31, 2010, it closed certain facilities in the United States and Mexico and it subleased its facility in Boston, Massachusetts.

http://www.google.com/finance?q=OFIX
👍️0

최근 히스토리

Delayed Upgrade Clock